Published in J Infect Dis on September 01, 1993
Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species. J Clin Microbiol (1995) 2.94
Analysis of Escherichia coli O157:H7 survival in ovine or bovine manure and manure slurry. Appl Environ Microbiol (1998) 2.13
Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis. J Clin Microbiol (2001) 1.99
Reduction of carriage of enterohemorrhagic Escherichia coli O157:H7 in cattle by inoculation with probiotic bacteria. J Clin Microbiol (1998) 1.63
Occurrence of verocytotoxin-producing Escherichia coli O157 on Dutch dairy farms. J Clin Microbiol (1998) 1.47
Long-term survival of shiga toxin-producing Escherichia coli O26, O111, and O157 in bovine feces. Appl Environ Microbiol (1999) 1.24
Associations between indicators of livestock farming intensity and incidence of human Shiga toxin-producing Escherichia coli infection. Emerg Infect Dis (2002) 1.21
Cattle can be a reservoir of sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H(-) strains and a source of human diseases. J Clin Microbiol (2000) 1.16
Risk factors for sporadic Shiga toxin-producing Escherichia coli infections in children, Argentina. Emerg Infect Dis (2008) 1.06
Prevalence of Escherichia coli O157 in Saskatchewan cattle: characterization of isolates by using random amplified polymorphic DNA PCR, antibiotic resistance profiles, and pathogenicity determinants. Appl Environ Microbiol (2006) 0.96
Association between indicators of cattle density and incidence of paediatric haemolytic-uraemic syndrome (HUS) in children under 15 years of age in France between 1996 and 2001: an ecological study. Epidemiol Infect (2005) 0.87
Outbreak of Escherichia coli 0157:H7 related to animal contact at a petting zoo. Can J Infect Dis (2002) 0.84
Humans and cattle: a review of bovine zoonoses. Vector Borne Zoonotic Dis (2013) 0.84
Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni. Hum Vaccin Immunother (2015) 0.84
Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin. Infect Immun (2014) 0.82
Epidemiology of infection due to Escherichia coli O157: a 3-year prospective study. Epidemiol Infect (1996) 0.79
Osmotic and desiccation tolerance in Escherichia coli O157:H7 requires rpoS (σ(38)). Curr Microbiol (2012) 0.78
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis (1985) 16.43
Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors. J Clin Microbiol (1982) 10.32
The Nutrition of Brucellae: Growth in Simple Chemically Defined Media. J Bacteriol (1948) 8.51
Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J Clin Microbiol (1994) 8.37
A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis (1987) 8.19
Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol (1999) 6.66
Bovine reservoir for verotoxin-producing Escherichia coli O157:H7. Lancet (1987) 5.63
Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol (1990) 5.41
Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis (1988) 5.30
New, extended biotyping scheme for Campylobacter jejuni, Campylobacter coli, and "Campylobacter laridis". J Clin Microbiol (1984) 5.01
Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada. Lancet (1983) 4.70
Mechanism of biological nitrogen fixation: Molecular H(2) and the pN(2) function of azotobacter. Biochem J (1941) 4.45
A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home. N Engl J Med (1987) 4.16
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect Immun (1987) 3.96
Amplification of an invA gene sequence of Salmonella typhimurium by polymerase chain reaction as a specific method of detection of Salmonella. Mol Cell Probes (1992) 3.58
A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb Pathog (1988) 3.31
Some structural and biological properties of Brucella endotoxin. Infect Immun (1970) 3.26
A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb Pathog (1988) 3.24
Surface antigens of smooth brucellae. J Bacteriol (1968) 3.24
Use of DNA probes and HEp-2 cell adherence assay to detect diarrheagenic Escherichia coli. J Infect Dis (1988) 3.19
Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity (1998) 3.10
Extended phage-typing scheme for Escherichia coli O157:H7. Epidemiol Infect (1990) 3.02
Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis (1988) 3.01
Use of the flagellar H7 gene as a target in multiplex PCR assays and improved specificity in identification of enterohemorrhagic Escherichia coli strains. J Clin Microbiol (1997) 2.98
Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains. J Clin Microbiol (1991) 2.97
Further evidence associating hemolytic uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7. J Infect Dis (1986) 2.92
Antigenic analysis of Campylobacter flagellar protein and other proteins. J Clin Microbiol (1985) 2.92
Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. J Clin Microbiol (1981) 2.82
Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol (1991) 2.78
Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol Infect (1994) 2.70
Vero cytotoxigenic Escherichia coli infection in dairy farm families. J Infect Dis (1996) 2.56
Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology (2000) 2.50
Rapid biochemical test to identify verocytotoxin-positive strains of Escherichia coli serotype O157. J Clin Microbiol (1990) 2.36
Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. Toxicol Sci (2000) 2.30
The cold-water coral Lophelia pertusa (Scleractinia) and enigmatic seabed mounds along the north-east Atlantic margin: are they related? Mar Pollut Bull (2003) 2.30
Hypoferremia in mice and its application to the bioassay of endotoxin. J Bacteriol (1965) 2.25
Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Fundam Appl Toxicol (1996) 2.22
Chemical composition and biological properties of the endotoxin of Brucella abortus. J Bacteriol (1965) 2.21
Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants. Pediatr Res (1994) 2.18
In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PDBEs, and polybrominated bisphenol A compounds. Environ Health Perspect (2001) 2.16
Outbreak of recurrent abdominal cramps associated with Arcobacter butzleri in an Italian school. J Clin Microbiol (1992) 2.11
The evaluation of a fluorogenic polymerase chain reaction assay for the detection of Salmonella species in food commodities. Int J Food Microbiol (1997) 2.08
The active compression test: a new and effective test for diagnosing labral tears and acromioclavicular joint abnormality. Am J Sports Med (1998) 2.03
Differentiation of genes coding for Escherichia coli verotoxin 2 and the verotoxin associated with porcine edema disease (VTe) by the polymerase chain reaction. J Clin Microbiol (1990) 2.02
Antigenic relationship of the gram-negative organism causing canine abortion to smooth and rough brucellae. J Bacteriol (1968) 1.96
Antigenic relationship of Brucella ovis and Brucella melitensis. J Bacteriol (1967) 1.94
Salmonella typhimurium DT104: a virulent and drug-resistant pathogen. Can Vet J (1998) 1.87
Magnitude and distribution of acute, self-reported gastrointestinal illness in a Canadian community. Epidemiol Infect (2004) 1.82
Isolation of verocytotoxin-producing Escherichia coli from milk filters in south-western Ontario. Epidemiol Infect (1989) 1.77
Hemorrhagic colitis due to Escherichia coli O157:H7. A rare disease? CMAJ (1986) 1.73
A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators. Epidemiol Infect (1993) 1.72
Distribution and characteristics of verocytotoxigenic Escherichia coli isolated from Ontario dairy cattle. Epidemiol Infect (1992) 1.72
Polymerase chain reaction for detection of verocytotoxigenic Escherichia coli isolated from animal and food sources. Mol Cell Probes (1992) 1.67
Sources of salmonellae in an uninfected commercially-processed broiler flock. Can J Comp Med (1980) 1.67
Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors. Antimicrob Agents Chemother (1985) 1.61
Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing. Anaesth Intensive Care (2014) 1.57
Prevalence of verocytotoxigenic Escherichia coli in ground beef, pork, and chicken in southwestern Ontario. Epidemiol Infect (1990) 1.57
Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p-dioxins and -dibenzofurans with human transthyretin. Chem Biol Interact (1993) 1.52
Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry (1998) 1.51
Determination of the glycosylated hemoglobins (HB AI) with a new microcolumn procedure. Suitability of the technique for assessing the clinical management of diabetes mellitus. Diabetes (1978) 1.51
Serotyping by slide agglutination of Campylobacter jejuni and epidemiology. Lancet (1981) 1.51
Persistence of Escherichia coli O157:H7 in dairy cattle and the dairy farm environment. Epidemiol Infect (1997) 1.51
Yersinia enterocolitica infection: report of two cases. Can J Public Health (1973) 1.49
Pregnancy, abortion, and birth rates among US adolescents--1980, 1985, and 1990. JAMA (1996) 1.49
Fenamates: a novel class of reversible gap junction blockers. J Pharmacol Exp Ther (2001) 1.49
Cytotoxic and cytotonic factors produced by Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis. J Clin Microbiol (1986) 1.48
Associations among antimicrobial drug treatments and antimicrobial resistance of fecal Escherichia coli of swine on 34 farrow-to-finish farms in Ontario, Canada. Prev Vet Med (1998) 1.45
Prevalence of the eaeA gene in verotoxigenic Escherichia coli strains from dairy cattle in Southwest Ontario. Epidemiol Infect (1996) 1.45
A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. J Infect Dis (1995) 1.43
False positive identifications of Escherichia coli O157. Lancet (1987) 1.43
Breast abscess associated with Helcococcus kunzii. J Clin Microbiol (1998) 1.43
Severe nasal clefting and abnormal embryonic apoptosis in Alx3/Alx4 double mutant mice. Development (2001) 1.42
Colitis in calves: natural and experimental infection with a verotoxin-producing strain of Escherichia coli O111:NM. Can J Vet Res (1988) 1.42
Prx1 and Prx2 in skeletogenesis: roles in the craniofacial region, inner ear and limbs. Development (1998) 1.42
Antibiotic resistance among predominant Salmonella serovars and phagovars in Canada. Can J Microbiol (1978) 1.42
Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci (1999) 1.42
Individual and group antimicrobial usage rates on 34 farrow-to-finish swine farms in Ontario, Canada. Prev Vet Med (1998) 1.41
An improved method for quantitative determination of human fetal hemoglobin. Anal Biochem (1970) 1.41
Taxonomic position in the genus Brucella of the causative agent of canine abortion. J Bacteriol (1968) 1.40
[Antithrombotic therapy after myocardial infarction: arguments for the use of acetylsalicylic acid and coumarin derivatives]. Ned Tijdschr Geneeskd (2005) 1.39
Hb Sun Prairie or alpha(2)130(H13)Ala----Pro beta 2, a new unstable variant occurring in low quantities. Hemoglobin (1990) 1.39
Cytotoxicity and suckling mouse reactivity of Aeromonas hydrophila isolated from human sources. Can J Microbiol (1981) 1.38
Temporal and geographical distributions of reported cases of Escherichia coli O157:H7 infection in Ontario. Epidemiol Infect (1999) 1.38
Perisinusoidal fat-storing cells are the main vitamin A storage sites in rat liver. Exp Cell Res (1985) 1.37